Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity
Launched by MAYO CLINIC · Jun 18, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at how fat tissue just under the skin in the upper body responds after eating a mixed meal, especially comparing people with obesity to those with normal weight. Researchers want to understand how tiny particles called exosomes, which cells release and use to communicate, behave in this fat tissue and in the blood after a meal. This might help us learn more about how obesity affects the body’s response to food.
The study is open to adults of all genders, but women must be premenopausal (meaning they have not yet gone through menopause). People who take certain medications that affect blood flow or fat metabolism, have diabetes or heart disease, are pregnant, or allergic to lidocaine (a numbing medicine) cannot join. Participants will have a small tube placed in a vein near the upper belly to collect samples before and after eating. This helps researchers study the fat tissue’s response in detail. The study is not yet enrolling volunteers but aims to include those between about 65 and 75 years old.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • All women must be premenopausal
- Exclusion Criteria:
- • Participants taking medications know to affect blood flow (statins, β-blockers) or fatty acid or adipose tissue metabolism (TZDs, high dose fish oil supplements)
- • Diabetes, history of cardiovascular disease
- • Allergy to lidocaine
- • Post-menopausal women
- • Pregnant
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Kelli A Lytle
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported